Jump to main navigation Skip to Content

DFG Logo: back to Homepage Deutsche Forschungsgemeinschaft

Working Groups

The Commission has set up working groups for specific task areas in which non-members of the Commission who have particular expertise in the respective areas can also participate.

Research and Health Policy Frameworks for Clinical Research / IT Infrastructures for Clinical Research

The working group Research and Health Policy Frameworks for Clinical Research deals with issues such as the structural development of university medicine in Germany and its impacts on clinical research, as well as the information technology requirements for clinical research.

Members of the working group

  • Professor Dr. Klaus-Michael Debatin (chair)
  • Professor Dr.-Ing. Georg Duda
  • Professor Dr. Simone Fulda
  • Professor Dr. Heyo Klaus Kroemer (deputy chair)
  • Professor Dr. Georg Peters

Statements (available in German only)

Promotion of Personnel Structure Concepts and Freedom of Scope in Research

This working group deals with issues such as mapping a consistent career path for young medical researchers (Clinician Scientists) and the need for a continuous and structured career for researchers in clinical practice (Advanced Clinician Scientists) at the levels of Facharzt (resident[p1] ) to Oberarzt (assistant medical director).

Members of the working group

  • Professor Dr. Annette Grüters-Kieslich (chair)
  • Professor Dr. Christopher Baum
  • Professor Dr. Simone Fulda
  • Professor Dr. Jörg C. Kalff
  • Professor Dr. Christine Klein
  • Professor Dr. Elke Roeb
  • Professor Dr. Ruth Esther von Stebut-Borschitz
  • Dr. Frank Wissing

Statement

Quality in Clinical Research

In the past few years, the quality of clinical research has once again become the topic of national and international discussions. The Senate Commission began to engage in this discussion during the first term of its mandate and in March 2015 it organised a workshop on this topic.

The working group Quality in Clinical Research is concerned with the principles and requirements of the DFG in relation to the quality of clinical research, in a subject-specific approach.

Members of the working group

  • Professor Dr. Bernd Fleischmann (chair)
  • Professor Dr. Christopher Baum
  • Professor Dr. Klaus-Michael Debatin
  • Professor Dr. Simone Fulda
  • Professor Dr. Wolfgang Herr (deputy chair)
  • Professor Dr. Andreas Meyer-Lindenberg
  • Professor Dr. Georg Peters
  • Professor Dr. Ruth Esther von Stebut-Borschitz
  • Dr. Frank Wissing

Translation: Transfer of Results from Clinical Research

This working group examines in a focused way the question of translation with respect to clinical research and areas of the life sciences which are of relevance to medicine.

Members of the working group

  • Professor Dr.-Ing. Georg Duda (chair)
  • Professor Dr. Klaus-Michael Debatin
  • Professor Dr. Simone Fulda
  • Professor Dr. Annette Grüters-Kieslich
  • Professor Dr. Wieland B. Huttner
  • Professor Dr. Christine Klein
  • Professor Dr. Heyo Klaus Kroemer
  • Professor Dr. Andreas Meyer-Lindenberg
  • Professor Dr. Georg Peters
  • Professor Dr. Erika von Mutius

Clinical Trials

This working group examines how the general conditions for conducting clinical trials in Germany can be improved. The working group collaborates closely with the Medicine Committee of the German Council of Science and Humanities, in some cases through joint meetings.

Members of the working group

  • Professor Dr. Hendrik Schulze-Koops (chair)
  • Professor Dr. Christopher Baum
  • Professor Dr. Annette Grüters-Kieslich
  • Professor Dr. Wolfgang Herr
  • Professor Dr. Andreas Meyer-Lindenberg
  • Professor Dr. Erika von Mutius
  • Professor Dr. Elke Roeb
  • Dr. Frank Wissing

Permanent guests of the working group from the Medicine Committee of the German Council of Science and Humanities

  • Professor Dr. Anja Bosserhoff
  • Professor Dr. Simone Fulda
  • Professor Dr. Michael Roden
  • Professor Dr. Stefan Zeuzem

Studies with Small Numbers of Cases

This working group is concerned with the question of how knowledge-generating studies with small numbers of cases can be designed to facilitate progress in the development of innovative therapies for rare diseases and personalised medicine.

Concluded working groups

Human Genome Sequencing

This working group was composed of members of the SCCR and the Senate Commission on Genetic Research and a member of the review board for human genetics and dealt with the ethical and legal aspects of human genome sequencing. This working group has concluded its work.

Statement

© 2010-2017 by DFG
Printable version of a page from the website of the DFG (German Research Foundation)